BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Risacher SL, Saykin AJ. Neuroimaging biomarkers of neurodegenerative diseases and dementia. Semin Neurol. 2013;33:386-416. [PMID: 24234359 DOI: 10.1055/s-0033-1359312] [Cited by in Crossref: 93] [Cited by in F6Publishing: 63] [Article Influence: 10.3] [Reference Citation Analysis]
Number Citing Articles
1 Padala SP, Newhouse PA. Blood-based biomarkers in Alzheimer’s disease: a mini-review. Metab Brain Dis 2022. [DOI: 10.1007/s11011-022-01114-1] [Reference Citation Analysis]
2 Yang J, Wang Z, Fu Y, Xu J, Zhang Y, Qin W, Zhang Q. Prediction value of the genetic risk of type 2 diabetes on the amnestic mild cognitive impairment conversion to Alzheimer’s disease. Front Aging Neurosci 2022;14:964463. [DOI: 10.3389/fnagi.2022.964463] [Reference Citation Analysis]
3 Abdelnour C, Agosta F, Bozzali M, Fougère B, Iwata A, Nilforooshan R, Takada LT, Viñuela F, Traber M. Perspectives and challenges in patient stratification in Alzheimer’s disease. Alz Res Therapy 2022;14:112. [DOI: 10.1186/s13195-022-01055-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Nanayakkara ND, Arnott SR, Scott CJM, Solovey I, Liang S, Fonov VS, Gee T, Broberg DN, Haddad SMH, Ramirez J, Berezuk C, Holmes M, Adamo S, Ozzoude M, Theyers A, Sujanthan S, Zamyadi M, Casaubon L, Dowlatshahi D, Mandzia J, Sahlas D, Saposnik G, Hassan A, Swartz RH, Strother SC, Szilagyi GM, Black SE, Symons S, Investigators ONDRI, Bartha R. Increased brain volumetric measurement precision from multi-site 3D T1-weighted 3 T magnetic resonance imaging by correcting geometric distortions. Magn Reson Imaging 2022:S0730-725X(22)00099-6. [PMID: 35753643 DOI: 10.1016/j.mri.2022.06.005] [Reference Citation Analysis]
5 Yang D, Masurkar A. Early-Stage MRI Volumetric Differences in White Matter Hyperintensity and Temporal Lobe Volumes between Autopsy-Confirmed Alzheimer’s Disease, Cerebral Small Vessel Disease, and Mixed Pathologies. Dement Geriatr Cogn Disord Extra. [DOI: 10.1159/000524499] [Reference Citation Analysis]
6 Rajput R, Kaur R, Chadha R, Mani S, Rachana R., Kaur H, Singh M. The Aging Brain. Research Anthology on Supporting Healthy Aging in a Digital Society 2022. [DOI: 10.4018/978-1-6684-5295-0.ch008] [Reference Citation Analysis]
7 Bonilauri A, Sangiuliano Intra F, Baselli G, Baglio F. Assessment of fNIRS Signal Processing Pipelines: Towards Clinical Applications. Applied Sciences 2021;12:316. [DOI: 10.3390/app12010316] [Reference Citation Analysis]
8 Nanayakkara ND, Arnott SR, Scott CJ, Solovey I, Liang S, Fonov VS, Gee T, Broberg DN, Haddad SM, Ramirez J, Berezuk C, Holmes M, Adamo S, Ozzoude M, Theyers A, Sujanthan S, Zamyadi M, Casaubon L, Dowlatshahi D, Mandzia J, Sahlas D, Saposnik G, Hassan A, Swartz RH, Strother SC, Szilagyi GM, Black SE, Symons S, Bartha R, ONDRI Investigators. Increased Brain Volumetric Measurement Precision from Multi-Site 3D T1-weighted 3T Magnetic Resonance Imaging by Correcting Geometric Distortions.. [DOI: 10.1101/2021.11.29.469919] [Reference Citation Analysis]
9 Kuhn T, Becerra S, Duncan J, Spivak N, Dang BH, Habelhah B, Mahdavi KD, Mamoun M, Whitney M, Pereles FS, Bystritsky A, Jordan SE. Translating state-of-the-art brain magnetic resonance imaging (MRI) techniques into clinical practice: multimodal MRI differentiates dementia subtypes in a traditional clinical setting. Quant Imaging Med Surg 2021;11:4056-73. [PMID: 34476189 DOI: 10.21037/qims-20-1355] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Pemberton HG, Zaki LAM, Goodkin O, Das RK, Steketee RME, Barkhof F, Vernooij MW. Technical and clinical validation of commercial automated volumetric MRI tools for dementia diagnosis-a systematic review. Neuroradiology 2021;63:1773-89. [PMID: 34476511 DOI: 10.1007/s00234-021-02746-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
11 Al-Nuaimi AH, Blūma M, Al-Juboori SS, Eke CS, Jammeh E, Sun L, Ifeachor E. Robust EEG Based Biomarkers to Detect Alzheimer's Disease. Brain Sci 2021;11:1026. [PMID: 34439645 DOI: 10.3390/brainsci11081026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Bandyopadhyay S. Role of Neuron and Glia in Alzheimer's Disease and Associated Vascular Dysfunction. Front Aging Neurosci 2021;13:653334. [PMID: 34211387 DOI: 10.3389/fnagi.2021.653334] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
13 Lamberti N, Manfredini F, Baroni A, Crepaldi A, Lavezzi S, Basaglia N, Straudi S. Motor Cortical Activation Assessment in Progressive Multiple Sclerosis Patients Enrolled in Gait Rehabilitation: A Secondary Analysis of the RAGTIME Trial Assisted by Functional Near-Infrared Spectroscopy. Diagnostics (Basel) 2021;11:1068. [PMID: 34207923 DOI: 10.3390/diagnostics11061068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Maasakkers CM, Thijssen DH, Knight SP, Newman L, O'Connor JD, Scarlett S, Carey D, Buckley A, McMorrow JP, Leidhin CN, Feeney J, Melis RJ, Kenny RA, Claassen JA, Looze C. Hemodynamic and structural brain measures in high and low sedentary older adults. J Cereb Blood Flow Metab 2021;:271678X211009382. [PMID: 33866848 DOI: 10.1177/0271678X211009382] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
15 Fishman KN, Roberts AC, Orange JB, Sunderland KM, Marras C, Tan B, Steeves T, Kwan D, Lang AE, Grimes D, Levine B, Masellis M, Binns MA, Jog M, Strother SC, Investigators O, McLaughlin PM, Troyer AK. Bilingualism in Parkinson's disease: Relationship to cognition and quality of life. J Clin Exp Neuropsychol 2021;43:199-212. [PMID: 33827353 DOI: 10.1080/13803395.2021.1902946] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Rosa-neto P, Shin M, Pascoal TA, Benedet AL, Chamoun M, Soucy J, Quispialayasocualaya K, Gauthier S. A Young Missionary with Problems Quoting the Bible. Case Studies in Dementia 2021. [DOI: 10.1017/9781316941294.002] [Reference Citation Analysis]
17 De La Garza R, Rodrigo H, Fernandez F, Roy U. The Increase of HIV-1 Infection, Neurocognitive Impairment, and Type 2 Diabetes in The Rio Grande Valley. Curr HIV Res 2019;17:377-87. [PMID: 31663481 DOI: 10.2174/1570162X17666191029162235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Wu Y. Microstructural imaging of the human brain with normal and “abnormal” aging using diffusion magnetic resonance imaging. Factors Affecting Neurological Aging 2021. [DOI: 10.1016/b978-0-12-817990-1.00013-5] [Reference Citation Analysis]
19 Goethe EA, Kass NR, Kass JS. Neurologic Disease in HIV Infection. Current Clinical Neurology 2021. [DOI: 10.1007/978-3-030-56084-3_9] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Zhu Y, Kim M, Zhu X, Kaufer D, Wu G; Alzheimer's Disease Neuroimaging Initiative. Long range early diagnosis of Alzheimer's disease using longitudinal MR imaging data. Med Image Anal 2021;67:101825. [PMID: 33137699 DOI: 10.1016/j.media.2020.101825] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
21 Pizzagalli F, Auzias G, Yang Q, Mathias SR, Faskowitz J, Boyd JD, Amini A, Rivière D, McMahon KL, de Zubicaray GI, Martin NG, Mangin JF, Glahn DC, Blangero J, Wright MJ, Thompson PM, Kochunov P, Jahanshad N. The reliability and heritability of cortical folds and their genetic correlations across hemispheres. Commun Biol 2020;3:510. [PMID: 32934300 DOI: 10.1038/s42003-020-01163-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 11.5] [Reference Citation Analysis]
22 Skolariki K, Exarchos T, Vlamos P. Contributing factors to Alzheimer’s Disease and biomarker identification techniques. 2020 5th South-East Europe Design Automation, Computer Engineering, Computer Networks and Social Media Conference (SEEDA-CECNSM) 2020. [DOI: 10.1109/seeda-cecnsm49515.2020.9221838] [Reference Citation Analysis]
23 van Veen R, Gurvits V, Kogan RV, Meles SK, de Vries GJ, Renken RJ, Rodriguez-Oroz MC, Rodriguez-Rojas R, Arnaldi D, Raffa S, de Jong BM, Leenders KL, Biehl M. An application of generalized matrix learning vector quantization in neuroimaging. Comput Methods Programs Biomed 2020;197:105708. [PMID: 32977181 DOI: 10.1016/j.cmpb.2020.105708] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
24 Bonilauri A, Sangiuliano Intra F, Pugnetti L, Baselli G, Baglio F. A Systematic Review of Cerebral Functional Near-Infrared Spectroscopy in Chronic Neurological Diseases-Actual Applications and Future Perspectives. Diagnostics (Basel) 2020;10:E581. [PMID: 32806516 DOI: 10.3390/diagnostics10080581] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
25 Risacher SL, Saykin AJ. Neuroimaging in aging and neurologic diseases. Handb Clin Neurol 2019;167:191-227. [PMID: 31753134 DOI: 10.1016/B978-0-12-804766-8.00012-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
26 Hedderich DM, Dieckmeyer M, Andrisan T, Ortner M, Grundl L, Schön S, Suppa P, Finck T, Kreiser K, Zimmer C, Yakushev I, Grimmer T. Normative brain volume reports may improve differential diagnosis of dementing neurodegenerative diseases in clinical practice. Eur Radiol 2020;30:2821-9. [PMID: 32002640 DOI: 10.1007/s00330-019-06602-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
27 Farooqui AA. Insulin resistance, dementia, and depression. Insulin Resistance as a Risk Factor in Visceral and Neurological Disorders 2020. [DOI: 10.1016/b978-0-12-819603-8.00008-0] [Reference Citation Analysis]
28 Hiscox LV, Johnson CL, McGarry MDJ, Marshall H, Ritchie CW, van Beek EJR, Roberts N, Starr JM. Mechanical property alterations across the cerebral cortex due to Alzheimer's disease. Brain Commun 2020;2:fcz049. [PMID: 31998866 DOI: 10.1093/braincomms/fcz049] [Cited by in Crossref: 31] [Cited by in F6Publishing: 37] [Article Influence: 10.3] [Reference Citation Analysis]
29 Tampi RR, Young JJ, Tampi D. Behavioral symptomatology and psychopharmacology of Lewy body dementia. Handb Clin Neurol 2019;165:59-70. [PMID: 31727230 DOI: 10.1016/B978-0-444-64012-3.00005-8] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Pizzagalli F, Auzias G, Yang Q, Mathias SR, Faskowitz J, Boyd J, Amini A, Rivière D, Mcmahon KL, de Zubicaray GI, Martin NG, Mangin J, Glahn DC, Blangero J, Wright MJ, Thompson PM, Kochunov P, Jahanshad N. The reliability and heritability of cortical folds and their genetic correlations across hemispheres.. [DOI: 10.1101/795591] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
31 Rossini P, Di Iorio R, Bentivoglio M, Bertini G, Ferreri F, Gerloff C, Ilmoniemi R, Miraglia F, Nitsche M, Pestilli F, Rosanova M, Shirota Y, Tesoriero C, Ugawa Y, Vecchio F, Ziemann U, Hallett M. Methods for analysis of brain connectivity: An IFCN-sponsored review. Clinical Neurophysiology 2019;130:1833-58. [DOI: 10.1016/j.clinph.2019.06.006] [Cited by in Crossref: 66] [Cited by in F6Publishing: 67] [Article Influence: 22.0] [Reference Citation Analysis]
32 Petrone PM, Casamitjana A, Falcon C, Artigues M, Operto G, Cacciaglia R, Molinuevo JL, Vilaplana V, Gispert JD; Alzheimer’s Disease Neuroimaging Initiative. Prediction of amyloid pathology in cognitively unimpaired individuals using voxel-wise analysis of longitudinal structural brain MRI. Alzheimers Res Ther 2019;11:72. [PMID: 31421683 DOI: 10.1186/s13195-019-0526-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
33 Goodkin O, Pemberton H, Vos SB, Prados F, Sudre CH, Moggridge J, Cardoso MJ, Ourselin S, Bisdas S, White M, Yousry T, Thornton J, Barkhof F. The quantitative neuroradiology initiative framework: application to dementia. Br J Radiol 2019;92:20190365. [PMID: 31368776 DOI: 10.1259/bjr.20190365] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
34 Fiocco AJ, Krieger L, D'Amico D, Parrott MD, Laurin D, Gaudreau P, Greenwood C, Ferland G. A systematic review of existing peripheral biomarkers of cognitive aging: Is there enough evidence for biomarker proxies in behavioral modification interventions?: An initiative in association with the nutrition, exercise and lifestyle team of the Canadian Consortium on Neurodegeneration in Aging. Ageing Res Rev 2019;52:72-119. [PMID: 31059801 DOI: 10.1016/j.arr.2019.04.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
35 Bouts MJRJ, Möller C, Hafkemeijer A, van Swieten JC, Dopper E, van der Flier WM, Vrenken H, Wink AM, Pijnenburg YAL, Scheltens P, Barkhof F, Schouten TM, de Vos F, Feis RA, van der Grond J, de Rooij M, Rombouts SARB. Single Subject Classification of Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia Using Anatomical, Diffusion Tensor, and Resting-State Functional Magnetic Resonance Imaging. J Alzheimers Dis 2018;62:1827-39. [PMID: 29614652 DOI: 10.3233/JAD-170893] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
36 Pascual Sanchis F, Tudela Torras P, Malventi Bellido D, Pedrós Roselló A. Anosognosia como síntoma inicial de la enfermedad de Alzheimer. A propósito de un caso. Psiquiatría Biológica 2019;26:62-65. [DOI: 10.1016/j.psiq.2019.06.002] [Reference Citation Analysis]
37 Lee Y, Chung J, Kwon HS, Koh SH, Lee KY, Lee YJ, Choi H. A Sudden Deterioration in Cognitive Functions as the Result of a Central Nervous System Lymphoma. Dement Neurocogn Disord 2018;17:71-2. [PMID: 30906395 DOI: 10.12779/dnd.2018.17.2.71] [Reference Citation Analysis]
38 Feis RA, Bouts MJRJ, Panman JL, Jiskoot LC, Dopper EGP, Schouten TM, de Vos F, van der Grond J, van Swieten JC, Rombouts SARB. Single-subject classification of presymptomatic frontotemporal dementia mutation carriers using multimodal MRI. Neuroimage Clin 2019;22:101718. [PMID: 30827922 DOI: 10.1016/j.nicl.2019.101718] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
39 Cilento EM, Jin L, Stewart T, Shi M, Sheng L, Zhang J. Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases. J Neurochem 2019;151:397-416. [PMID: 30474862 DOI: 10.1111/jnc.14635] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
40 Jovicich J, Barkhof F, Babiloni C, Herholz K, Mulert C, van Berckel BNM, Frisoni GB; SRA-NED JPND Working Group. Harmonization of neuroimaging biomarkers for neurodegenerative diseases: A survey in the imaging community of perceived barriers and suggested actions. Alzheimers Dement (Amst) 2019;11:69-73. [PMID: 31673595 DOI: 10.1016/j.dadm.2018.11.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
41 Farooqui AA. Neurochemical Aspects of Dementia. Molecular Mechanisms of Dementia 2019. [DOI: 10.1016/b978-0-12-816347-4.00001-5] [Reference Citation Analysis]
42 Rajput R, Kaur R, Chadha R, Mani S, Rachana R., Kaur H, Singh M. The Aging Brain. Advances in Medical Diagnosis, Treatment, and Care 2019. [DOI: 10.4018/978-1-5225-5282-6.ch001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Delvecchio G, Mandolini GM, Arighi A, Prunas C, Mauri CM, Pietroboni AM, Marotta G, Cinnante CM, Triulzi FM, Galimberti D, Scarpini E, Altamura AC, Brambilla P. Structural and metabolic cerebral alterations between elderly bipolar disorder and behavioural variant frontotemporal dementia: A combined MRI-PET study. Aust N Z J Psychiatry 2019;53:413-23. [DOI: 10.1177/0004867418815976] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
44 Kautzky A, Seiger R, Hahn A, Fischer P, Krampla W, Kasper S, Kovacs GG, Lanzenberger R. Prediction of Autopsy Verified Neuropathological Change of Alzheimer's Disease Using Machine Learning and MRI. Front Aging Neurosci 2018;10:406. [PMID: 30618713 DOI: 10.3389/fnagi.2018.00406] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
45 Nho K, Kueider-Paisley A, MahmoudianDehkordi S, Arnold M, Risacher SL, Louie G, Blach C, Baillie R, Han X, Kastenmüller G, Jia W, Xie G, Ahmad S, Hankemeier T, van Duijn CM, Trojanowski JQ, Shaw LM, Weiner MW, Doraiswamy PM, Saykin AJ, Kaddurah-Daouk R; Alzheimer's Disease Neuroimaging Initiative and the Alzheimer Disease Metabolomics Consortium. Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers. Alzheimers Dement 2019;15:232-44. [PMID: 30337152 DOI: 10.1016/j.jalz.2018.08.012] [Cited by in Crossref: 119] [Cited by in F6Publishing: 128] [Article Influence: 29.8] [Reference Citation Analysis]
46 O'Neill BE, Hochhalter CB, Carr C, Strong MJ, Ware ML. Advances in Neuro-Oncology Imaging Techniques. Ochsner J 2018;18:236-41. [PMID: 30275788 DOI: 10.31486/toj.17.0062] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
47 Janelidze M, Botchorishvili N. Mild Cognitive Impairment. Alzheimer's Disease - The 21st Century Challenge 2018. [DOI: 10.5772/intechopen.75509] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
48 Feis RA, Bouts MJRJ, Panman JL, Jiskoot LC, Dopper EGP, Schouten TM, de Vos F, van der Grond J, van Swieten JC, Rombouts SARB. Single-subject classification of presymptomatic frontotemporal dementia mutation carriers using multimodal MRI. Neuroimage Clin 2018;20:188-96. [PMID: 30094168 DOI: 10.1016/j.nicl.2018.07.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
49 Pfefferbaum A, Zahr NM, Sassoon SA, Kwon D, Pohl KM, Sullivan EV. Accelerated and Premature Aging Characterizing Regional Cortical Volume Loss in Human Immunodeficiency Virus Infection: Contributions From Alcohol, Substance Use, and Hepatitis C Coinfection. Biol Psychiatry Cogn Neurosci Neuroimaging 2018;3:844-59. [PMID: 30093343 DOI: 10.1016/j.bpsc.2018.06.006] [Cited by in Crossref: 30] [Cited by in F6Publishing: 46] [Article Influence: 7.5] [Reference Citation Analysis]
50 Kong V, Devenyi GA, Gallino D, Ayranci G, Germann J, Rollins C, Chakravarty MM. Early-in-life neuroanatomical and behavioural trajectories in a triple transgenic model of Alzheimer’s disease. Brain Struct Funct 2018;223:3365-82. [DOI: 10.1007/s00429-018-1691-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
51 Csincsik L, MacGillivray TJ, Flynn E, Pellegrini E, Papanastasiou G, Barzegar-Befroei N, Csutak A, Bird AC, Ritchie CW, Peto T, Lengyel I. Peripheral Retinal Imaging Biomarkers for Alzheimer's Disease: A Pilot Study. Ophthalmic Res 2018;59:182-92. [PMID: 29621759 DOI: 10.1159/000487053] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 9.8] [Reference Citation Analysis]
52 Koenig AM, Nobuhara CK, Williams VJ, Arnold SE. Biomarkers in Alzheimer's, Frontotemporal, Lewy Body, and Vascular Dementias. Focus (Am Psychiatr Publ) 2018;16:164-72. [PMID: 31975911 DOI: 10.1176/appi.focus.20170048] [Reference Citation Analysis]
53 Nho K, Kueider-paisley A, Mahmoudiandehkordi S, Arnold M, Risacher SL, Louie G, Blach C, Baillie R, Han X, Kastenmüller G, Jia W, Xie G, Ahmad S, Hankemeier T, van Duijn CM, Trojanowski JQ, Shaw LM, Weiner MW, Doraiswamy PM, Saykin AJ, Kaddurah-daouk R, for the Alzheimer’s Disease Neuroimaging Initiative and the Alzheimer Disease Metabolomics Consortium. Altered Bile Acid Profile in Mild Cognitive Impairment and Alzheimer’s Disease: Relationship to Neuroimaging and CSF Biomarkers.. [DOI: 10.1101/284141] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
54 Miletich RS. Positron Emission Tomography and Single-Photon Emission Computed Tomography in Neurology. Continuum (Minneap Minn) 2016;22:1636-54. [PMID: 27740992 DOI: 10.1212/CON.0000000000000389] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
55 Baker JD, Webster JM, Shelton LB, Koren J, Uversky VN, Blair LJ, Dickey CA. Neurodegenerative Diseases as Protein Folding Disorders. The Molecular and Cellular Basis of Neurodegenerative Diseases 2018. [DOI: 10.1016/b978-0-12-811304-2.00009-2] [Reference Citation Analysis]
56 Multi-Infarct Dementia. Specialty Imaging: PET 2018. [DOI: 10.1016/b978-0-323-52484-1.50074-1] [Reference Citation Analysis]
57 Toufexis D, King SB, Michopoulos V. Socially Housed Female Macaques: a Translational Model for the Interaction of Chronic Stress and Estrogen in Aging. Curr Psychiatry Rep 2017;19:78. [PMID: 28905316 DOI: 10.1007/s11920-017-0833-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
58 Callahan BL, Bierstone D, Stuss DT, Black SE. Adult ADHD: Risk Factor for Dementia or Phenotypic Mimic? Front Aging Neurosci 2017;9:260. [PMID: 28824421 DOI: 10.3389/fnagi.2017.00260] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 6.4] [Reference Citation Analysis]
59 Iyappan A, Younesi E, Redolfi A, Vrooman H, Khanna S, Frisoni GB, Hofmann-Apitius M; Alzheimer’s Disease Neuroimaging Initiative. Neuroimaging Feature Terminology: A Controlled Terminology for the Annotation of Brain Imaging Features. J Alzheimers Dis 2017;59:1153-69. [PMID: 28731430 DOI: 10.3233/JAD-161148] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
60 Persson K, Selbæk G, Brækhus A, Beyer M, Barca M, Engedal K. Fully automated structural MRI of the brain in clinical dementia workup. Acta Radiol 2017;58:740-7. [PMID: 27687251 DOI: 10.1177/0284185116669874] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
61 ElSheikh M, Arani A, Perry A, Boeve BF, Meyer FB, Savica R, Ehman RL, Huston J 3rd. MR Elastography Demonstrates Unique Regional Brain Stiffness Patterns in Dementias. AJR Am J Roentgenol 2017;209:403-8. [PMID: 28570101 DOI: 10.2214/AJR.16.17455] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 9.0] [Reference Citation Analysis]
62 Zhu Y, Zhu X, Kim M, Wu G. A Novel Dynamic Hyper-Graph Inference Framework for Computer Assisted Diagnosis of Neuro-Diseases. Inf Process Med Imaging 2017;10265:158-69. [PMID: 30245556 DOI: 10.1007/978-3-319-59050-9_13] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
63 Ward PGD, Ferris NJ, Raniga P, Ng ACL, Barnes DG, Dowe DL, Egan GF. Vein segmentation using shape-based Markov Random Fields. 2017 IEEE 14th International Symposium on Biomedical Imaging (ISBI 2017) 2017. [DOI: 10.1109/isbi.2017.7950716] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
64 Afrashteh N, Inayat S, Mohsenvand M, Mohajerani MH. Optical-flow analysis toolbox for characterization of spatiotemporal dynamics in mesoscale optical imaging of brain activity. Neuroimage 2017;153:58-74. [PMID: 28351691 DOI: 10.1016/j.neuroimage.2017.03.034] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 6.4] [Reference Citation Analysis]
65 Xiong L, Boulouis G, Charidimou A, Roongpiboonsopit D, Jessel MJ, Pasi M, Reijmer YD, Fotiadis P, Ayres A, Merrill E, Schwab K, Blacker D, Gurol ME, Greenberg SM, Viswanathan A. Dementia incidence and predictors in cerebral amyloid angiopathy patients without intracerebral hemorrhage. J Cereb Blood Flow Metab 2018;38:241-9. [PMID: 28318355 DOI: 10.1177/0271678X17700435] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
66 Verlinden VJA, van der Geest JN, Hofman A, Niessen WJ, van der Lugt A, Vernooij MW, Ikram MA. Brain MRI-markers Associate Differentially with Cognitive Versus Functional Decline Leading to Dementia. J Am Geriatr Soc 2017;65:1258-66. [DOI: 10.1111/jgs.14775] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
67 Nemoto K. Brain Perfusion SPECT in Alzheimer’s Disease. Neuroimaging Diagnosis for Alzheimer's Disease and Other Dementias 2017. [DOI: 10.1007/978-4-431-55133-1_11] [Reference Citation Analysis]
68 Afrashteh N, Inayat S, Mohsenvand M, Mohajerani MH. Optical-flow analysis toolbox for characterization of spatiotemporal dynamics in mesoscale optical imaging of brain activity.. [DOI: 10.1101/087676] [Reference Citation Analysis]
69 Tatarnikova OG, Orlov MA, Bobkova NV. Beta-Amyloid and Tau-Protein: Structure, Interaction, and Prion-Like Properties. Biochemistry (Mosc) 2015;80:1800-19. [PMID: 26878581 DOI: 10.1134/S000629791513012X] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
70 Zhu Y, Zhu X, Kim M, Shen D, Wu G. Early Diagnosis of Alzheimer's Disease by Joint Feature Selection and Classification on Temporally Structured Support Vector Machine. Med Image Comput Comput Assist Interv 2016;9900:264-72. [PMID: 28149964 DOI: 10.1007/978-3-319-46720-7_31] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
71 Peck KJ, Girard TA, Russo FA, Fiocco AJ. Music and Memory in Alzheimer’s Disease and The Potential Underlying Mechanisms. JAD 2016;51:949-59. [DOI: 10.3233/jad-150998] [Cited by in Crossref: 41] [Cited by in F6Publishing: 47] [Article Influence: 6.8] [Reference Citation Analysis]
72 Narayanan L, Murray AD. What can imaging tell us about cognitive impairment and dementia? World J Radiol 2016; 8(3): 240-254 [PMID: 27029053 DOI: 10.4329/wjr.v8.i3.240] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
73 Li JQ, Wang HF, Zhu XC, Sun FR, Tan MS, Tan CC, Jiang T, Tan L, Yu JT; Alzheimer’s Disease Neuroimaging Initiative. GWAS-Linked Loci and Neuroimaging Measures in Alzheimer's Disease. Mol Neurobiol 2017;54:146-53. [PMID: 26732597 DOI: 10.1007/s12035-015-9669-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
74 Multi-Infarct Dementia. Diagnostic Imaging: Nuclear Medicine 2016. [DOI: 10.1016/b978-0-323-37753-9.50020-7] [Reference Citation Analysis]
75 Creutzfeldt-Jakob Disease (CJD). Diagnostic Imaging: Brain 2016. [DOI: 10.1016/b978-0-323-37754-6.50284-0] [Reference Citation Analysis]
76 Acquired HIV Encephalitis. Diagnostic Imaging: Brain 2016. [DOI: 10.1016/b978-0-323-37754-6.50220-7] [Reference Citation Analysis]
77 Frontotemporal Lobar Degeneration. Diagnostic Imaging: Brain 2016. [DOI: 10.1016/b978-0-323-37754-6.50282-7] [Reference Citation Analysis]
78 Frontotemporal Lobar Degeneration. Imaging in Neurology 2016. [DOI: 10.1016/b978-0-323-44781-2.50191-1] [Reference Citation Analysis]
79 Acquired HIV Encephalitis. Imaging in Neurology 2016. [DOI: 10.1016/b978-0-323-44781-2.50146-7] [Reference Citation Analysis]
80 Creutzfeldt-Jakob Disease (CJD), Classic. Imaging in Neurology 2016. [DOI: 10.1016/b978-0-323-44781-2.50193-5] [Reference Citation Analysis]
81 Chung Y, Madhu B, Griffiths JR. Metabolism and Metabolomics by MRS. eMagRes 2015. [DOI: 10.1002/9780470034590.emrstm1461] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
82 Verlinden VJ, van der Geest JN, de Bruijn RF, Hofman A, Koudstaal PJ, Ikram MA. Trajectories of decline in cognition and daily functioning in preclinical dementia. Alzheimer's & Dementia 2016;12:144-53. [DOI: 10.1016/j.jalz.2015.08.001] [Cited by in Crossref: 71] [Cited by in F6Publishing: 72] [Article Influence: 10.1] [Reference Citation Analysis]
83 Segobin S, La Joie R, Ritz L, Beaunieux H, Desgranges B, Chételat G, Pitel AL, Eustache F. FDG-PET Contributions to the Pathophysiology of Memory Impairment. Neuropsychol Rev 2015;25:326-55. [DOI: 10.1007/s11065-015-9297-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
84 Taswell C, Villemagne VL, Yates P, Shimada H, Leyton CE, Ballard KJ, Piguet O, Burrell JR, Hodges JR, Rowe CC. 18 F-FDG PET Improves Diagnosis in Patients with Focal-Onset Dementias. J Nucl Med 2015;56:1547-53. [DOI: 10.2967/jnumed.115.161067] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
85 Kotrotsou A, Schneider JA, Bennett DA, Leurgans SE, Dawe RJ, Boyle PA, Golak T, Arfanakis K. Neuropathologic correlates of regional brain volumes in a community cohort of older adults. Neurobiol Aging 2015;36:2798-805. [PMID: 26195068 DOI: 10.1016/j.neurobiolaging.2015.06.025] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 4.3] [Reference Citation Analysis]
86 Rodriguez-oroz MC, Gago B, Clavero P, Delgado-alvarado M, Garcia-garcia D, Jimenez-urbieta H. The Relationship Between Atrophy and Hypometabolism: Is It Regionally Dependent in Dementias? Curr Neurol Neurosci Rep 2015;15. [DOI: 10.1007/s11910-015-0562-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
87 Lu H, Zhu XC, Jiang T, Yu JT, Tan L. Body fluid biomarkers in Alzheimer's disease. Ann Transl Med 2015;3:70. [PMID: 25992369 DOI: 10.3978/j.issn.2305-5839.2015.02.13] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
88 Bodea SV, Mühl-Benninghaus R. [MRI in dementia-type diseases]. Radiologe 2015;55:397-402. [PMID: 25944274 DOI: 10.1007/s00117-014-2798-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
89 Alrwaily M, Whitney S, Holmberg J. A physical therapist classification system for persons with complaints of dizziness and balance dysfunction. Physical Therapy Reviews 2015;20:110-21. [DOI: 10.1179/1743288x15y.0000000004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
90 Bohm C, Chen F, Sevalle J, Qamar S, Dodd R, Li Y, Schmitt-Ulms G, Fraser PE, St George-Hyslop PH. Current and future implications of basic and translational research on amyloid-β peptide production and removal pathways. Mol Cell Neurosci 2015;66:3-11. [PMID: 25748120 DOI: 10.1016/j.mcn.2015.02.016] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 7.0] [Reference Citation Analysis]
91 Tedaldi EM, Minniti NL, Fischer T. HIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbidities. Biomed Res Int 2015;2015:641913. [PMID: 25815329 DOI: 10.1155/2015/641913] [Cited by in Crossref: 67] [Cited by in F6Publishing: 78] [Article Influence: 9.6] [Reference Citation Analysis]
92 Peterson J, Gisslen M, Zetterberg H, Fuchs D, Shacklett BL, Hagberg L, Yiannoutsos CT, Spudich SS, Price RW. Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection. PLoS One 2014;9:e116081. [PMID: 25541953 DOI: 10.1371/journal.pone.0116081] [Cited by in Crossref: 73] [Cited by in F6Publishing: 78] [Article Influence: 9.1] [Reference Citation Analysis]
93 Bozluolcay M, Elmali AD, Menku SF, Zeydan B, Benbir G, Delil S, Yeni N. Magnetic resonance imaging findings in probable Creutzfeld-Jacob disease: comparison with electroencephalography and cerebrospinal fluid characteristics. Acta Radiol Short Rep 2014;3:2047981614552218. [PMID: 25535567 DOI: 10.1177/2047981614552218] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
94 Grassetto G, Marzola MC, Musto A, Viniamury S, Colletti PM, Perkins AC, Rubello D. Non-Alzheimer types of neurodegenerative dementia: clinical and 18F-FDG-PET/CT pictures. Nuclear Medicine Communications 2014;35:1085-92. [DOI: 10.1097/mnm.0000000000000191] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
95 Arevalo-Rodriguez I, Segura O, Solà I, Bonfill X, Sanchez E, Alonso-Coello P. Diagnostic tools for alzheimer's disease dementia and other dementias: an overview of diagnostic test accuracy (DTA) systematic reviews. BMC Neurol 2014;14:183. [PMID: 25248284 DOI: 10.1186/s12883-014-0183-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
96 Hill JM, Clement C, Pogue AI, Bhattacharjee S, Zhao Y, Lukiw WJ. Pathogenic microbes, the microbiome, and Alzheimer's disease (AD). Front Aging Neurosci 2014;6:127. [PMID: 24982633 DOI: 10.3389/fnagi.2014.00127] [Cited by in Crossref: 49] [Cited by in F6Publishing: 83] [Article Influence: 6.1] [Reference Citation Analysis]